Related Experiment Video
Updated: May 31, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
D-dimer plasma levels in NSTE-ACS patient
Nisarat Charoensri1, Suwatchai Pornratanarangsi
1Division of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Insights
Plasma D-dimer levels correlate with the extent of coronary artery disease in non-ST elevation acute coronary syndrome (NSTE-ACS) patients. Elevated D-dimer indicates more severe obstruction and predicts in-hospital cardiovascular complications.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Acute Coronary Syndrome (ACS) involves plaque rupture, leading to thrombogenesis and myocardial injury.
- Plasma D-dimer, a fibrin degradation product, serves as a marker of fibrinolysis during coronary artery occlusion.
Purpose of the Study:
- To investigate the relationship between plasma D-dimer levels and the severity of coronary artery obstruction in non-ST elevation ACS (NSTE-ACS) patients.
- Severity was assessed using angiographic data, including the number of affected coronary arteries and degree of lumen stenosis.
Main Methods:
- 74 NSTE-ACS patients were enrolled, with exclusions for conditions elevating D-dimer unrelated to NSTE-ACS.
- Plasma D-dimer levels were measured, and coronary angiography was performed to evaluate stenosis severity.
Main Results:
- D-dimer levels significantly increased with the number of coronary arteries affected (p=0.03).
- A trend for increased D-dimer was observed with higher percentages of coronary artery stenosis (p=0.30).
- Plasma D-dimer correlated with NSTE-ACS complications (heart failure, arrhythmia, death) and was higher in patients treated with CABG.
Conclusions:
- Plasma D-dimer is a valuable marker for assessing the extent of coronary artery involvement in NSTE-ACS.
- D-dimer may predict in-hospital cardiovascular complications in these patients.
Background:
Acute Coronary Syndrome (ACS) occurs when a vulnerable plaque ruptures and induces platelet aggregation and coagulation process at the rupture. Thrombogenesis is the final process that forms a clot in the coronary lumen causing myocardial injury. Plasma D-dimer, a primary degradation product and circulating marker offibrin turnover, serves as a direct marker of ongoing fibrinolysis in site of coronary artery occlusion.
Objective:
To determine the correlation between plasma D-dimer levels and severity of coronary artery obstruction based on angiographic data that is composed of the number of coronary arteries affected and the percentage of maximum stenosis of coronary artery lumen in non-ST elevation ACS (NSTE-ACS) patients.
Material And Method:
NSTE-ACS patients who admitted in Siriraj hospital duringJune 2009 and March 2010 were enrolled. Conditions that increased plasma D-dimer other than NSTE-ACS were excluded. Demographic characteristics were assessed by a standardized questionnaire. Plasma D-dimer was measured and coronary angiography was performed to evaluate severity of coronary artery stenosis.
Results:
Total of 74 NSTE-ACS patients were enrolled (29 in unstable angina and 45 in non-ST elevation myocardial infarction). Mean age of these patients (54.1% in female and 45.9% in male) were 66 years. D-Dimer was significantly increased with the number of coronary arteries affected (p = 0.03). In non-significant and single coronary artery disease (CAD) patients, median D-dimer was 406 (178-2,788) mcg/L. In multivessel CAD, median D-dimer was 941 (131-7,110) mcg/L. D-dimer levels had a trend to be increased with percentage of maximum stenosis of coronary artery lumen; atheromatosis, (p = 0.30). In mild and moderate atheromatosis (coronary artery stenosis < 70%), median D-dimer was 479 (182-5902) mcg/L while median D-dimer was 789 (131-7110) mcg/L in severe atheromatosis (coronary artery stenosis > 70%). Moreover plasma D-dimer levels correlated with complication of NSTE-ACS (Congestive heartfailure; p < 0.001, arrhythmia; p = 0.007 and death; p = 0.009) and was increased in patients who underwent treatment with CABG more often than those who received PCI and medication treatment alone. D-dimer also correlated with serum creatinine (r = 0.517, p < 0.001), creatinine clearance (r = -0.463, p < 0.001), troponin-T level (r = 0.381, p < 0.001) and left ventricular ejection fraction (r = -0.368, p = 0.002).
Conclusion:
D-dimer is useful coagulation marker use to evaluate extent of coronary affected and may predict in-hospital CV complication. However, other conditions that increased plasma D-dimer also excluded.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
